Package 45802-400-49

Brand: ciclopirox olamine

Generic: ciclopirox olamine
NDC Package

Package Facts

Identity

Package NDC 45802-400-49
Digits Only 4580240049
Product NDC 45802-400
Product ID 45802-400_ae67550c-f609-40a6-8f0c-8909d360de0b
Description

1 BOTTLE in 1 CARTON (45802-400-49) / 30 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2006-12-29
Brand ciclopirox olamine
Generic ciclopirox olamine
Sample Package No

Linked Drug Pages (1)

Ciclopirox Olamine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "ae67550c-f609-40a6-8f0c-8909d360de0b", "openfda": {"unii": ["50MD4SB4AP"], "rxcui": ["309290"], "spl_set_id": ["eadbd29d-5990-4987-833f-40cd0b2d2868"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (45802-400-46)  / 60 mL in 1 BOTTLE", "package_ndc": "45802-400-46", "marketing_start_date": "20061229"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (45802-400-49)  / 30 mL in 1 BOTTLE", "package_ndc": "45802-400-49", "marketing_start_date": "20061229"}], "brand_name": "Ciclopirox Olamine", "product_id": "45802-400_ae67550c-f609-40a6-8f0c-8909d360de0b", "dosage_form": "SUSPENSION", "pharm_class": ["Decreased DNA Replication [PE]", "Decreased Protein Synthesis [PE]", "Decreased RNA Replication [PE]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "45802-400", "generic_name": "Ciclopirox Olamine", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ciclopirox Olamine", "active_ingredients": [{"name": "CICLOPIROX OLAMINE", "strength": "7.7 mg/100mL"}], "application_number": "ANDA077676", "marketing_category": "ANDA", "marketing_start_date": "20061229", "listing_expiration_date": "20261231"}